BDSX vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

BDSX

42.2
AI Score
VS
BDSX Wins

CDNA

24.9
AI Score

Investment Advisor Scores

BDSX

42score
Recommendation
HOLD

CDNA

25score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BDSX CDNA Winner
Revenue 76.46M 389.01M CDNA
Net Income -23.10M 132.74M CDNA
Net Margin -30.2% 34.1% CDNA
Operating Income -17.70M 122.53M CDNA
ROE -266.3% 28.4% CDNA
ROA -24.6% 20.7% CDNA
Total Assets 93.94M 641.46M CDNA
Cash 28.41M 250.48M CDNA
Current Ratio 2.96 2.31 BDSX
Free Cash Flow -19.77M 40.36M CDNA

Relative Price Performance (Last 90 Days)

BDSX 1M: -61.0% · 3M: -58.6% CDNA 1M: +28.0% · 3M: +70.7%

Current Technical Phase

BDSX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 24

RSI (14): 23.9 · Price: $10.02

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.0% over 20 days), RSI 59

RSI (14): 59.2 · Price: $80.77

Fundamentals Snapshot

Metric BDSX CDNA
Market Cap — —
Forward P/E -5.8 51.2
Trailing P/E — 35.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.8% 0.7%
Operating Margin -0.3% 0.1%
EPS -2.69 2.37
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BDSX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.